Howard E. Gendelman, MD
Item
Title
Howard E. Gendelman, MD
Description
Howard E. Gendelman, MD, is credited in unraveling how functional alterations in brain immunity induce metabolic changes and ultimately lead to neural cell damage for a broad range of infectious, metabolic and neurodegenerative disorders. These discoveries have had broad implications in developmental therapeutics aimed at preventing, slowing or reversing neural maladies. He is also credited for the demonstration that AIDS dementia is a reversible metabolic encephalopathy; a finding realized at UNMC. His work has led to novel immunotherapy and nanomedicine strategies for Parkinson’s and viral diseases being tested in early clinical trials as a result of intense translational investigations.
Dr. Gendelman has trained more than forty scientists (students and postdoctoral fellows) who have themselves developed independent successful careers in academia and industry. His leadership is credited with the growth of the Department of Pharmacology and Experimental Neuroscience at UNMC to be amongst the top-like ranked and federally funded departments (top ten) nationwide; a particularly noted feat as its position was 89 when he assumed its leadership. That position has been held for more than a decade.
Dr. Gendelman has trained more than forty scientists (students and postdoctoral fellows) who have themselves developed independent successful careers in academia and industry. His leadership is credited with the growth of the Department of Pharmacology and Experimental Neuroscience at UNMC to be amongst the top-like ranked and federally funded departments (top ten) nationwide; a particularly noted feat as its position was 89 when he assumed its leadership. That position has been held for more than a decade.
Rights
Courtesy of the University of Nebraska Medical Center, Office of Strategic Communications